Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 4/20 | 0.53 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.53 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.52 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.51 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4065856 | 1.00 | MEN1 (0.53) | MEN1KMT2AALDH1A1HPGDSIRT2 | |
| SCHEMBL9838107 | 1.00 | MEN1 (0.53) | MEN1KMT2AALDH1A1HPGDSIRT2 | |
| SCHEMBL22271575 | 1.00 | MEN1 (0.53) | MEN1KMT2AALDH1A1HPGDSIRT2 | |
| SCHEMBL8162401 | 1.00 | MEN1 (0.53) | MEN1KMT2AALDH1A1HPGDSIRT2 | |
| SCHEMBL18729465 | 0.94 | FOLH1 (0.53) | — | |
| SCHEMBL17767808 | 0.94 | FOLH1 (0.53) | — | |
| SCHEMBL17832976 | 0.92 | KMT2A (0.64) | MEN1KMT2AALDH1A1HPGDSIRT2 | |
| SCHEMBL15931039 | 0.91 | SIRT2 (0.55) | MEN1KMT2AALDH1A1HPGDSIRT2 | |
| SCHEMBL28252935 | 0.89 | SIRT2 (0.51) | MEN1KMT2AALDH1A1HPGDSIRT2 | |
| SCHEMBL28252938 | 0.89 | SIRT2 (0.51) | MEN1KMT2AALDH1A1HPGDSIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1956000-B1 | ACYLATING AGENTS USEFUL FOR ACYLATING PEPTIDES | NOVO NORDISK AS (DK) | 2016-10-05 | — | — | EP | disclosed |
| EP-1163211-B1 | METHOD FOR ACYLATING PEPTIDES AND PROTEINS | NOVO NORDISK AS (DK) | 2008-09-24 | — | — | EP | disclosed |
| EP-1956000-A1 | Acylating agents useful for acylating peptides | Novo Nordisk A/S (DK) | 2008-08-13 | — | — | EP | disclosed |
| US-6451974-B1 | GLUTAMIC ACID DERIVATIVE; SAPONIFICATION; RACEMIZATION PREVENTION | NOVO NORDISK A/S (DK) | 2002-09-17 | — | — | US | disclosed |
| CN-1344248-A | Method for acylating peptides and novel acylating agents | NOVO NORDISK AS (DK) | 2002-04-10 | — | — | CN | disclosed |
| EP-1163211-A1 | METHOD FOR ACYLATING PEPTIDES AND NOVEL ACYLATING AGENTS | NOVO NORDISK A/S (DK) | 2001-12-19 | — | — | EP | disclosed |
| WO-2000055119-A1 | METHOD FOR ACYLATING PEPTIDES AND NOVEL ACYLATING AGENTS | NOVO NORDISK A/S (DK) | 2000-09-21 | — | — | WO | disclosed |